21 May 2013
Keywords: gsk, lead, malaria, vaccine, candidate, begin, ph
Article | 14 July 2003
The first Phase II pediatric trial of GlaxoSmithKline's malaria vaccine candidate, RTS/AS02A, is to be initiated in Mozambique, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 July 2003
20 May 2013
© 2013 thepharmaletter.com